BUFFIE HENDRIX: Open Payments
NPI 1760900336 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 22 payments from 12 companies in 2025. Trend: 2023 $1,118 · 2024 $389 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $130 |
| Medtronic, Inc. | 2 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Impulse Dynamics (USA) Inc. | 1 | $32 |
| Amgen Inc. | 2 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: WATCHMAN FLX, COREVALVE EVOLUT R, LEQVIO, FARXIGA, ELIQUIS, Optimizer, REPATHA, LifeVest.
Industry payments across KS — which companies pay providers there.
